Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma
1996

Thymidine Phosphorylase and Hepatic Metastasis in Gastric Cancer

Sample size: 120 publication Evidence: moderate

Author Information

Author(s): K Maeda, Y-S Chung, Y Ogawa, S Takatsuka, S-M Kang, M Ogawa, T Sawada, N Onoda, Y Kato, M Sowa

Primary Institution: Osaka City University Medical School

Hypothesis

Is there a correlation between thymidine phosphorylase expression and hepatic metastasis in gastric carcinoma?

Conclusion

Thymidine phosphorylase expression is associated with increased angiogenesis and a higher frequency of hepatic metastasis in gastric carcinoma.

Supporting Evidence

  • Thymidine phosphorylase was expressed in 60.8% of gastric carcinoma cases.
  • Microvessel density was significantly higher in thymidine phosphorylase-positive tumors.
  • Hepatic metastasis was significantly more frequent in patients with thymidine phosphorylase-positive tumors.

Takeaway

This study found that a protein called thymidine phosphorylase is linked to more blood vessel growth and more liver spread in stomach cancer.

Methodology

Immunohistochemical staining was used to assess thymidine phosphorylase expression and microvessel density in resected gastric carcinoma specimens.

Limitations

The study did not establish thymidine phosphorylase as an independent prognostic factor.

Participant Demographics

Patients aged 40 to 81 years, with 87 men and 33 women.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication